Skip to main content

Rebif

Pronunciation: re-bif
Generic name: interferon beta-1a
Brand names: Rebif, Rebif Rebidose
Dosage form: single-dose prefilled syringe for subcutaneous use, single-dose prefilled autoinjector for subcutaneous use
Drug class: Interferons

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 2, 2025.

What is Rebif?

Rebif is used to treat relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

Rebif’s mechanism of action resembles that of interferons which are proteins naturally produced by our immune system that help regulate the body’s immune response and fight viral infections. Rebif is a man-made form of interferon that works in the same way, binding to specific receptors on cell surfaces and decreasing the activity of immune cells that attack the myelin sheath, reducing inflammation in the central nervous system, and helping to suppress the autoimmune response that characterizes MS.

Rebif belongs to the drug class called interferons. It may also be called an immunomodulator. Rebif will not cure MS, it will only decrease the frequency of relapse symptoms.

Rebif gained FDA approval on March 7, 2002. Another brand of interferon beta-1a given intramuscularly (into a muscle) called Avonex, was the first interferon beta-1a to be approved (May 17, 1996). There is no Rebif generic.

Rebif side effects

The most common side effects of Rebif are:

Serious side effects and warnings

Rebif can cause the following serious side effects.

Behavioral health problems including depression and suicidal thoughts. You may have mood problems while taking Rebif, for example, depression (feeling hopeless or feeling bad about yourself), or thoughts of hurting yourself or suicide. Contact your healthcare provider immediately.

Liver problems or liver failure has been reported in people taking Rebif. Contact your healthcare provider immediately if you develop any of the following symptoms:

Rebif may cause serious allergic and skin reactions. Contact your healthcare provider or seek emergency medical attention if you develop any of the following symptoms:

Injection site problems. Rebif may cause redness, pain, itching, or swelling at the place where your injection was given. Call your healthcare provider immediately if an injection site becomes swollen and painful or the area looks infected. You may have a skin infection or an area of severe skin damage (necrosis) requiring treatment by a healthcare provider.

Blood problems. Rebif can affect your bone marrow and cause low red and white blood cell, and platelet counts. In some people, these blood cell counts may fall to dangerously low levels. If your blood cell counts become very low, you can get infections and problems with bleeding and bruising. Your healthcare provider may ask you to have regular blood tests to check for blood problems.

Pulmonary arterial hypertension. Pulmonary arterial hypertension (high blood pressure in the arteries of the lungs) can occur with interferon beta products, including Rebif. Symptoms may include new fatigue or shortness of breath. Contact your healthcare provider right away if you develop these symptoms.

Thrombotic microangiopathy (TMA). TMA is a condition that involves injury to the smallest blood vessels in your body and this has been reported with Rebif. TMA can also cause injury to your red blood cells (the cells that carry oxygen to your organs and tissues) and your platelets (cells that help your blood clot) and can sometimes lead to death. Your healthcare provider may tell you to stop taking Rebif if you develop TMA.

Seizures. Some people have had seizures while taking Rebif.

Autoimmune diseases. Problems with easy bleeding or bruising (idiopathic thrombocytopenia), thyroid gland problems (hyperthyroidism and hypothyroidism), and autoimmune hepatitis have happened in some people who use Rebif.

Eye Disorders: Retinal disorders (such as retinopathy, cotton wool spots, or obstruction of
the retinal artery or vein) have been reported with Rebif. See your healthcare provider immediately if you have any changes in your vision or eye pain.

During your treatment with Rebif see your healthcare provider regularly and have regular blood tests to check for side effects.

Tell your healthcare provider if you have any side effect that bothers you or does not go away. These are not all the possible side effects of Rebif. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Before taking

Do not take Rebif if you are allergic to interferon beta-1a, human albumin, Rebif, Avonex, or any inactive ingredients in the injection (see below for a list of inactive ingredients).

Before you take Rebif, tell your healthcare provider if you have or have had any of the following conditions:

Pregnancy

It is not known if Rebif can harm your unborn baby.

Breastfeeding

Rebif may pass into your breast milk. Talk with your healthcare provider about the best way to feed your baby while taking this medicine.

How should I use Rebif?

See the Instructions for Use that come with the Rebif Package Insert.

How to inject Rebif for subcutaneous use

Rebif is given by injection under the skin (subcutaneous injection) on the same 3 days a week, for example, Monday, Wednesday, and Friday.

Your healthcare provider will tell you how much Rebif to inject and may change the dose based on how your body responds. 

Rebif comes as a:

Your healthcare provider will decide which is best for you. Always use a new, unopened, prefilled syringe or autoinjector for each injection. Do not reuse prefilled syringes or autoinjectors.

See the Rebif Package Insert for complete administration instructions.

Rebif dosing information

The recommended dose of Rebif for MS is either 22 micrograms or 44 micrograms injected subcutaneously, 3 times a week.

Titration: Generally, the starting dose should be 20% of the prescribed dose three times per week, and increased over 4 weeks to the targeted recommended dose of either 22 micrograms or 44 micrograms injected subcutaneously three times per week. Your healthcare provider will calculate this dose for you.

Pain and/or fever-relieving medicines on treatment days may help reduce side effects such as flu-like symptoms.

See the Rebif Prescribing Information for full dosing instructions.

What other drugs will affect Rebif?

Tell your healthcare provider about all medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Rebif and other medicines may affect each other causing side effects. Ask your healthcare provider or pharmacist for a list of these medicines, if you are not sure.

Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

Does Rebif interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

Storage

Store Rebif in the refrigerator between 36°F to 46°F (2°C to 8°C).

Do not freeze Rebif.

If you cannot refrigerate your Rebif pen or autoinjector, you can store it at temperatures above 36°F and below 77°F (2°C to 25°C) for up to 30 days.

Keep Rebif away from heat and light.

Rebif ingredients

Active ingredient: Rebif

Inactive ingredients: albumin (human), mannitol, sodium acetate, water for injection

Single-dose Rebif prefilled syringe is available as 8.8 mcg in 0.2 mL, and 22 mcg or 44 mcg in 0.5 mL.

Single-dose Rebif autoinjector is available as 8.8 mcg in 0.2 mL, and 22 mcg or 44 mcg in 0.5 mL.

Who makes Rebif?

EMD Serono Inc. makes Rebif.

Rebif Biosimilars

Biosimilar and interchangeable products are biological products that are highly similar to and have no clinically meaningful differences from the reference product.

Reference products

These are biological products that have already been approved by the FDA, against which biosimilar products are compared. There are 2 for Rebif.

Avonex (interferon beta-1a) - Biogen Inc.
Formulation type Strength
Autoinjector 30 mcg/0.5 mL
Pre-Filled Syringe 30 mcg/0.5 mL
Single-Dose Vial 30 mcg Discontinued

View Avonex information in detail.

Rebif (interferon beta-1a) - EMD Serono, Inc.
Formulation type Strength
Autoinjector 22 mcg/0.5 mL
Autoinjector 44 mcg/0.5 mL
Autoinjector 8.8 mcg/0.2 mL
Pre-Filled Syringe 22 mcg/0.5 mL
Pre-Filled Syringe 44 mcg/0.5 mL
Pre-Filled Syringe 8.8 mcg/0.2 mL

Popular FAQ

What are the long term side effects of Rebif?

Data from over two decades of clinical experience and studies have shown that most side effects of Rebif (interferon beta-1a) are temporary and reversible. More rare but long-term side effects may include liver damage, lung damage, and skin damage at the injection site. Continue reading

How effective is Rebif for MS?

Rebif (interferon beta-1a) is an injectable medication that may be used to treat relapsing forms of multiple sclerosis (MS). In studies, Rebif reduced MS exacerbations by up to 32% over 2 years compared to placebo. Continue reading

More FAQ

View more FAQ

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.